Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria
<p><strong>Background</strong> Treatment of Plasmodium vivax malaria requires the clearing of asexual parasites, but relapse can be prevented only if dormant hypnozoites are cleared from the liver (a treatment termed “radical cure”). Tafenoquine is a single-dose 8-aminoquinoline th...
Main Authors: | Lacerda, MVG, Llanos-Cuentas, A, Krudsood, S, Lon, C, Saunders, DL, Mohammed, R, Yilma, D, Batista Pereira, D, Espino, FEJ, Mia, RZ, Chuquiyauri, R, Val, F, Casapía, M, Monteiro, WM, Brito, MAM, Costa, MRF, Buathong, N, Noedl, H, Diro, E, Getie, S, Wubie, KM, Abdissa, A, Zeynudin, A, Abebe, C, Tada, MS, Brand, F, Beck, H-P, Angus, B, Duparc, S, Kleim, J-P, Kellam, LM, Rousell, VM, Jones, SW, Hardaker, E, Mohamed, K, Clover, DD, Fletcher, K, Breton, JJ, Ugwuegbulam, CO, Green, JA, Koh, GCKW |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
Massachusetts Medical Society
2019
|
פריטים דומים
-
Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
מאת: Llanos-Cuentas, A, et al.
יצא לאור: (2019) -
Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria
מאת: St Jean, PL, et al.
יצא לאור: (2020) -
The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis
מאת: Watson, JA, et al.
יצא לאור: (2022) -
Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis'
מאת: Watson, JA, et al.
יצא לאור: (2024) -
A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.
מאת: Mark M Fukuda, et al.
יצא לאור: (2017-01-01)